Intracellular Diffusion: How bacteria keep proteins moving

Bacteria contain large numbers of negatively-charged proteins to avoid the electrostatic interactions with ribosomes that would dramatically reduce protein diffusion.
  1. Conrad W Mullineaux  Is a corresponding author
  1. Queen Mary University of London, United Kingdom

The cytoplasm of a bacterial cell is densely packed with DNA, RNA and various proteins and macromolecules (Zimmerman and Trach, 1991). In Escherichia coli, for example, the cytoplasm is home to around two million soluble protein molecules (estimated using data from the BioNumbers database) and about 55,000 ribosomes (Bakshi et al., 2012; see also Goodsell, 2009 for vivid illustrations of the dense packing of the bacterial cytoplasm). This overcrowding can have profound effects on the biochemistry of the cytoplasm and on its physical properties (Ellis, 2001; Parry et al., 2014). However, despite being congested with macromolecules, the cytoplasm remains surprisingly fluid.

For decades, researchers have used green fluorescent proteins, also known as GFPs, to study how molecules move in living organisms, because GFPs can be tracked with a fluorescence microscope. GFPs diffuse rapidly: for example, one GFP molecule can travel the entire length of an E. coli cell in less than one second (Nenninger et al., 2010). However, adding a small positively-charged ‘tag’ to the negatively charged GFP slows its diffusion in E. coli (Elowitz et al., 1999).

Nevertheless, it has remained unclear what factors control the diffusion of proteins in the cytoplasm. Now, in eLife, Paul Schavemaker, Wojciech Śmigiel and Bert Poolman of the University of Groningen report that the total surface charge of proteins strongly influences their mobility (Schavemaker et al., 2017). By systematically increasing the positive surface charge of GFPs in E. coli and two other prokaryotes, Schavemaker et al. showed that proteins with a positive charge moved up to 100 times more slowly than proteins with a negative charge.

Schavemaker et al. take the story further with elegant experiments that identify the main culprit: the ribosome. Ribosomes are bulky structures with a negative surface charge that mainly comes from their RNA (Knight et al., 2013). Moreover, they regularly interact with other macromolecules when they are translating mRNA transcripts to produce new proteins. Schavemaker et al. estimate that each ribosome is big enough to trap up to 66 positively-charged GFP-sized proteins on its surface. This can stop ribosomes from working, cause the cytoplasm to clot, and hinder any process that depends on the free movement of proteins.

So, how can this problem be avoided? A simple but drastic solution would be to ban positively-charged proteins from the cytoplasm (as the remaining negatively-charged proteins will not be attracted to the ribosomes in the first place). In fact, this seems to be the solution adopted by most prokaryotes. It has long been known that in most organisms, the majority of proteins in the cytoplasm have net negative charge at physiological pH (Schwartz et al., 2001).

Indeed, Schavemaker et al.’s detailed analysis of three different species of prokaryotes indicates that, with the exception of a few nucleic-acid binding proteins and ribosomal subunits, the cytoplasm is almost devoid of positively-charged proteins. This hints at a strong and previously unsuspected evolutionary pressure to ensure that proteins in the cytoplasm are negatively-charged.

However, not all prokaryotes follow this rule. Schavemaker et al. identify four bacteria that mainly have positively-charged proteins inside their cytoplasm. It is not known how these bacteria prevent the cytoplasm from clotting, but it could be significant that all four have small genomes and live in symbiosis with a eukaryotic host. The situation in eukaryotes also warrants a closer look: do our ribosomes influence the mobility of the proteins in our cytoplasm?

The findings of Schavemaker et al. have clear implications for biotechnologists who wish to engineer bacteria to produce foreign proteins, as it could be problematic to produce positively-charged proteins. Synthetic biologists working on the ambitious goal of turning bacteria into cell factories that produce entirely new products (Nielsen and Keasling, 2016) should also be wary of introducing positively-charged proteins into the cytoplasm.

References

    1. Elowitz MB
    2. Surette MG
    3. Wolf PE
    4. Stock JB
    5. Leibler S
    (1999)
    Protein mobility in the cytoplasm of Escherichia coli
    Journal of Bacteriology 181:197–203.
    1. Goodsell DS
    (2009) Escherichia coli
    Biochemistry and Molecular Biology Education 37:325–332.
    https://doi.org/10.1002/bmb.20345

Article and author information

Author details

  1. Conrad W Mullineaux

    Conrad W Mullineaux is in the School of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom

    For correspondence
    c.mullineaux@qmul.ac.uk
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7194-9916

Publication history

  1. Version of Record published:

Copyright

© 2017, Mullineaux

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,467
    views
  • 268
    downloads
  • 3
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Conrad W Mullineaux
(2017)
Intracellular Diffusion: How bacteria keep proteins moving
eLife 6:e33590.
https://doi.org/10.7554/eLife.33590
  1. Further reading

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Jie Luo, Jeff Ranish
    Tools and Resources

    Dynamic conformational and structural changes in proteins and protein complexes play a central and ubiquitous role in the regulation of protein function, yet it is very challenging to study these changes, especially for large protein complexes, under physiological conditions. Here, we introduce a novel isobaric crosslinker, Qlinker, for studying conformational and structural changes in proteins and protein complexes using quantitative crosslinking mass spectrometry. Qlinkers are small and simple, amine-reactive molecules with an optimal extended distance of ~10 Å, which use MS2 reporter ions for relative quantification of Qlinker-modified peptides derived from different samples. We synthesized the 2-plex Q2linker and showed that the Q2linker can provide quantitative crosslinking data that pinpoints key conformational and structural changes in biosensors, binary and ternary complexes composed of the general transcription factors TBP, TFIIA, and TFIIB, and RNA polymerase II complexes.

    1. Biochemistry and Chemical Biology
    2. Stem Cells and Regenerative Medicine
    Alejandro J Brenes, Eva Griesser ... Angus I Lamond
    Research Article

    Human induced pluripotent stem cells (hiPSCs) have great potential to be used as alternatives to embryonic stem cells (hESCs) in regenerative medicine and disease modelling. In this study, we characterise the proteomes of multiple hiPSC and hESC lines derived from independent donors and find that while they express a near-identical set of proteins, they show consistent quantitative differences in the abundance of a subset of proteins. hiPSCs have increased total protein content, while maintaining a comparable cell cycle profile to hESCs, with increased abundance of cytoplasmic and mitochondrial proteins required to sustain high growth rates, including nutrient transporters and metabolic proteins. Prominent changes detected in proteins involved in mitochondrial metabolism correlated with enhanced mitochondrial potential, shown using high-resolution respirometry. hiPSCs also produced higher levels of secreted proteins, including growth factors and proteins involved in the inhibition of the immune system. The data indicate that reprogramming of fibroblasts to hiPSCs produces important differences in cytoplasmic and mitochondrial proteins compared to hESCs, with consequences affecting growth and metabolism. This study improves our understanding of the molecular differences between hiPSCs and hESCs, with implications for potential risks and benefits for their use in future disease modelling and therapeutic applications.